SGMO - SANGAMO THERAPEUTICS, INC

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 0.5614

Open

$ 0.53

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 0.52 - $ 0.59

52 Week Range

$ 0.29 - $ 1.67

Volume

4,769,970

Average Volume

Market Cap

101.24M

Beta (5Y Monthly)

$ 1.03

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-09-2024	03-31-2024	10-Q
2	03-13-2024	12-31-2023	10-K
3	11-01-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-08-2023	03-31-2023	10-Q
6	02-23-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	02-24-2022	12-31-2021	10-K
11	11-04-2021	09-30-2021	10-Q
12	08-05-2021	06-30-2021	10-Q
13	05-04-2021	03-31-2021	10-Q
14	02-24-2021	12-31-2020	10-K
15	11-04-2020	09-30-2020	10-Q
16	08-05-2020	06-30-2020	10-Q
17	05-11-2020	03-31-2020	10-Q
18	02-28-2020	12-31-2019	10-K
19	11-06-2019	09-30-2019	10-Q
20	08-07-2019	06-30-2019	10-Q
21	05-08-2019	03-31-2019	10-Q
22	03-01-2019	12-31-2018	10-K
23	11-08-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-01-2018	12-31-2017	10-K
27	11-09-2017	09-30-2017	10-Q
28	08-09-2017	06-30-2017	10-Q
29	05-10-2017	03-31-2017	10-Q
30	02-28-2017	12-31-2016	10-K
31	10-27-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-05-2016	03-31-2016	10-Q
34	02-18-2016	12-31-2015	10-K
35	10-30-2015	09-30-2015	10-Q
36	08-06-2015	06-30-2015	10-Q
37	04-28-2015	03-31-2015	10-Q
38	02-25-2015	12-31-2014	10-K
39	10-28-2014	09-30-2014	10-Q
40	07-29-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Sangamo Therapeutics Q1 2024 GAAP EPS $(0....
05/09/2024 20:30:15

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate o...

Sangamo Therapeutics Presents Modular Inte...
05/09/2024 12:45:44

Sangamo Therapeutics To Present Neurology-...
04/22/2024 20:36:23

12-health-care-stocks-moving-in-fridays-intraday-session

12 Health Care Stocks Moving In Friday's I...
03/22/2024 17:31:17

Sangamo Therapeutics Announces Pricing Of ...
03/22/2024 12:05:53

Sangamo Therapeutics, Inc. (NASDAQ:SGMO), a genomic medicine company, today announced that it has entered into a securities pur...

analyst-bullish-on-gene-therapy-focused-voyager-therapeutics-sees-best-in-class-potential-for-its-neurogenetic-medicine-platform

Analyst Bullish On Gene Therapy-Focused Vo...
03/19/2024 18:16:11

Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising...

HC Wainwright & Co. Reiterates Buy on Sang...
03/19/2024 10:25:40

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and raises the pri...

RBC Capital Reiterates Sector Perform on S...
03/14/2024 15:28:26

RBC Capital analyst Luca Issi reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Sector Perform and maintains $2 price tar...

4 Analysts Assess Sangamo Therapeutics: Wh...
03/13/2024 18:00:25

HC Wainwright & Co. Maintains Buy on Sanga...
03/13/2024 16:48:48

HC Wainwright & Co. analyst Patrick Trucchio maintains Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $3 pr...

Sangamo Therapeutics Expects Total Operati...
03/13/2024 12:16:56

Financial Guidance for 2024On a GAAP basis, we expect total operating expenses in the range of approximately $145 million to $1...

Sangamo Therapeutics Q4 EPS $(0.34) Misses...
03/13/2024 12:15:50

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate o...

Sangamo Therapeutics Announces Data From S...
03/13/2024 12:06:37

Earnings Scheduled For March 13, 2024
03/13/2024 10:15:56

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
02/19/2024 17:30:50

HC Wainwright & Co. Reiterates Buy on Sang...
02/12/2024 17:48:07

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $3 p...

12 Health Care Stocks Moving In Monday's I...
02/12/2024 17:31:18

Sangamo Therapeutics Announces FDA Alignme...
02/12/2024 13:06:17

- U.S. Food and Drug Administration (FDA) advises that a single study with up to 25 patients, in combination with confirmatory ...

HC Wainwright & Co. Reiterates Buy on Sang...
02/06/2024 13:49:19

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $3 p...

why-palantir-technologies-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket

Why Palantir Technologies Shares Are Tradi...
02/06/2024 13:16:16

Shares of Palantir Technologies Inc. (NYSE: PLTR) rose sharply during today’s pre-market trading after the company reported bet...